Advertisements

Peter Reynolds

The life and times of Peter Reynolds

Archive for the ‘food’ Category

Mischievous ‘Centre for Medicinal Cannabis’ Report Smears UK CBD Industry With Misleading Data

leave a comment »

A new report from the Centre for Medicinal Cannabis (CMC) paints an appalling picture of the CBD market in the UK and has led to headlines and alarm everywhere that consumers are being ripped off and the whole industry is not to be trusted.

Cannabis has great medical potential. But don’t fall for the CBD scam – The Guardian

Calling on the UK CBD sector to have better regulation and reform – Health Europa

Centre for Medicinal Cannabis survey finds six million adults used CBD in UK – NHS Executive

CBD oil brands contain little to no CBD, test by Sativa’s UK lab reveals – Proactive Investors

It is true that there are some rogue businesses and fake products but the impression given by this report is false, misleading and wildly inaccurate.  For nearly three years the leading CBD businesses in the UK have been engaged in serious, responsible self-regulation and consumers can be confident if they buy from members of the two trade associations Cannabis Professionals (CannaPro) or Cannabis Trades Association (CTA) they will be getting a quality product which is lab tested and contains exactly what is claimed.

The report is nothing but a market manipulation exercise by the authors. To understand why, it’s necessary to understand who is behind the ‘Centre for Medicinal Cannabis’ and examine their record.

The CMC is the latest front for Paul Birch, a multimillionaire, who since 2015 has been funding a series of ventures in the cannabis campaign. Mr Birch has brought one extremely valuable commodity to the campaign which it had been sorely lacking – money.  He has hired a lot of people with the right connections, impressive letters after their name and has thrown a great deal of his cash into expensive PR which, to be fair, has proved very effective. In fact, as with this CBD report, it is characterised by just how much media coverage it has obtained.  This, of course, has earned Birch’s cannabis ventures a reputation as leaders in their field. In fact, they are very much followers.  The content of their work is either directly copied from others’ work or is just a repeat of what has been done before.

The most high profile success achieved with Birch’s money and PR was the campaign around Billy Caldwell and Alfie Dingley, two children with severe epilepsy, whose stories touched the heart of the nation and under enormous moral pressure forced the UK government into long-overdue reform of its blanket ban on cannabis as medicine.  Birch’s money certainly made all the difference. Exactly the same stories and messages had been delivered to the media many times before but it is a fact of life that you only get on to the breakfast and daytime TV shows and in all the tabloids with a very expensive PR operation.

So Birch is at it again with the CMC. It describes itself as the UK’s first and only industry membership body for businesses and investors operating in cannabis based medicinal products (CBMPs) and cannabidiol (CBD) wellness markets.“, which is as wholly false a claim as has ever been published about anything, anywhere.

The existing trade associations, CannaPro and the CTA, were formed years before the CMC and between them represent nearly 1,000 businesses operating in the legal cannabis sector.  Neither of them were consulted before or since the CMC’s report and the fact of their existence and the work they do in regulating the industry has been excluded from the report.

Of course, the CMC won’t name the products which its report showed to be so deficient because this would show that they are not from members of CannaPro or CTA and are therefore not at all representative of what consumers are actually buying. The irony is that PhytoVista, the lab used by the CMC, is itself a member of the CTA and provides testing services to many CannaPro and CTA members.

So take the results of the CMC CBD report with a very large pinch of salt, or perhaps with a tablespoon of hempseed oil containing only a trace of CBD.  It doesn’t tell the truth. It paints a false picture of an industry that is actually a model of self-regulation.

Advertisements

Written by Peter Reynolds

July 9, 2019 at 3:38 pm

Review. Gincanna Hemp-Infused Gin

leave a comment »

Adding CBD oil to drinks has become de rigeur in the past year or two. Even Coca Cola has expressed interest in entering the market. So when I first heard of CBD-infused alcoholic drinks I was intrigued. Gincanna is a result of a joint venture between CBD company Ev8 Life and Selkirk Distillers and it certainly offers a new twist on your usual G&T.

It’s not about the therapeutic or ‘wellness’ properties of CBD, it’s about flavour, so gin is the obvious candidate for such an idea because it is essentially a neutral tasting spirit infused with juniper berries and other botanicals which give each product its individual flavour.

To those who find the taste of CBD oil quite disgusting this may seem strange! Please take it from me that cannabis can provide a very pleasant flavour ingredient if used properly.  The classic hash brownie is perhaps the best example. A good recipe delivers a delicious earthy, herbal richness which blends very well with moist chocolate cake. Gincanna successfuly achieves the same sort of alchemy and although it’s a completely different context, it’s equally delightful.

Taking my tasting responsibilities very seriously, I sampled Gincanna neat to begin with, not something I would usually do with gin.  The earthy taste is not very prominent but remarkably when you add tonic and lemon that seems to bring it out.

It’s a successful blend, more than just a talking point and with the boom in trendy gin brands this is something that could do very well. Gordons, Bombay Sapphire or Gincanna, the choice is yours and it will be good to see it offered in all the most fashionable bars and at the most sophisticated occasions.  I can personally verify that a Ginacanna and tonic goes down very well on a summer’s evening with a nice, fat joint!

Written by Peter Reynolds

June 12, 2019 at 4:08 pm

Posted in food, Product Review

Tagged with , , , ,

The CBD Market Can Help Drive Cannabis Law Reform But Selling So-Called ‘CBD Flowers’ Could Take Us Backwards

leave a comment »

Jim Weathers of Puff ‘n Stuff CBD shop, Cork, Ireland

Compliant businesses operating responsibly within the legal cannabis sector will help to drive reform. Blurring the lines between legal and illegal products will delay progress.

It seems that the crackdown on the open sale of cannabis flowers online and in high street stores is here.  Both in the UK and Ireland, several shops have been raided in recent weeks and some people are facing potential charges of supplying a class B drug and a possible jail sentence.

These flowers, sold under meaningless pseudonyms such as ‘CBD buds’ or ‘hemp flowers’ are cannabis and cannabis is a controlled drug in both the UK and Ireland.  As CLEAR has been warning for many months, there is no way that these can ever be ‘exempt products’ in the same way as CBD oil.  Their THC content makes no difference. The penalty is the same for any type of cannabis whether it contains zero THC or 25% THC.

It’s unclear whether CBD oil is legal at all in Ireland.  A more accurate description for these products is low-THC cannabis extracts and whereas the UK makes specific provision for exempt products in the Misuse of Drugs Regulations 2001, there does not seem to be any such provision in Irish law.

In other EU countries an even wider crackdown on CBD products is underway, fuelled also by the extraordinary and clearly unsustainable attempt to deem all cannabis extracts as ‘novel foods’.

Now it shouldn’t need to be said but CLEAR stands for an end to the prohibition of cannabis and all our work is directed towards that end.  Some people seem very confused that our efforts to clarify the law mean that we are on the side of prohibition but this is not the case.  Through our trade association, Cannabis Professionals (CannaPro) we refuse to certify businesses that sell cannabis flowers.  They are cheating their customers by misleading them that these products are legal.  They are also cheating all those other businesses operating within the legal cannabis sector who are working hard to remain compliant.  They are undermining the very good work that the CBD industry is doing to drive wider cannabis law reform.

Of course, many of us are buying cannabis illegally already.  Without our local dealers where would we all be under the oppressive and ridiculous regime under which we live? But our aim and the aim of all responsible cannabis campaigns is to ‘get the dealers off the street’ and move the trade into licensed, regulated outlets.  The emergence of the CBD market and high street retailers selling CBD oil has shown how this could work and there is no doubt at all that it has been a very significant factor in increasing public acceptance of cannabis and the recent reforms for medical access.

The people selling cannabis flowers and claiming they are legal are not heroes, campaigners or warriors in the war on prohibition. They are confidence tricksters, seizing the opportunity to make a quick buck by cheating and endangering their customers. No one is going to go to jail for buying cannabis but if you’ve bought low THC flowers and get charged with possession that could ruin you future prospects of travel, a career, even of keeping your driving licence.  If you’re going to take that risk you need to do so with your eyes open, with the honest trade of an illegal dealer rather than the dishonest trade of a shop or a website that is telling you lies.

Also, be very careful what you are buying.  The ‘CBD flowers’ currently being advertised are most certainly not what they claim to be.  The strain names are being misused.  White Widow, Lemon Haze or Pineapple Express do not come with 20% CBD and only traces of THC.  These products have been doctored.  There simply aren’t any cannabis strains that contain these constituents in these proportions.  What is probably happening is that they are being sprayed with CBD isolate and possibly terpene extracts to come with what are artificial cannabis buds.  Buy these and you are being cheated on many levels and you really don’t know what you are actually inhaling.

We are making steady and accelerating progress towards a rational cannabis policy but this latest development is unwelcome and unhelpful.  Trust your usual dealer.  If you’re buying cannabis flower, it comes with THC.  If you want added CBD take a little oil or vape some CBD crumble.  This will give you a far better result than these fake flowers. It will enhance the therapeutic properties of your cannabis if you’re consuming for medical reasons.  It will give you a far better buzz if you’re consuming for pleasure.

Nothing good will come from these fake flowers. Compliant businesses operating responsibly within the legal cannabis sector will help to drive reform. Blurring the lines between legal and illegal products will delay progress.

 

 

Written by Peter Reynolds

May 21, 2019 at 2:40 pm

The EU’s Attempt To Deem Cannabis Extracts As Novel Foods Will Fail.

with one comment

Status of Hemp Extracts in Europe – European Industrial Hemp Association

The European Industrial Hemp Association (EIHA) has published an excellent eight page document which refutes the recent move by EU food safety agencies to deem cannabis extracts as ‘novel foods’.

Download the document here.

The document explains the entire situation and demonstrates very clearly that this move by the EU is misguided. It shows how these products have been consumed in Europe fro many years, if not centuries, probably millennia and that the EU has previously confirmed in writing that they are not novel.

Aside from these fundamental issues, there are a number of reasons why the process the EU and the UK Food Standards Agency (FSA) have followed is flawed and unlawful.

What seems absolutely clear is that this initiative, which is intended to close down the burgeoning CBD market, is based on the intervention of vested interests which are concerned to see a multimillion pound/euro industry emerge in the space of a few years, almost exclusively amongst small and medium-sized businesses.  This is an opportunity which multinational conglomerates have missed and there is no doubt that its success is affecting many existing markets, notably over-the-counter pain medicines.

The EU and government agencies such as the FSA have always been the friends of big business and the intention here has been to force small business into huge costs associated with novel food authorisation which would effectively close their businesses down.

There are many overblown conspiracy theories, particularly around cannabis for medical use and the pharmaceutical industry but this attack on the CBD market, for no valid reason, is difficult to explain in any other way. It seems certain that improper pressure has been brought to bear on these regulators and they are trying to use their powers, improperly and unlawfully, to protect the interests of big business.

They are too late.  The CBD business has grown very quickly and is now too far advanced to be closed down and there is no justifiable reason to do so.  This attempt to impose novel foods status will fail.

 

Written by Peter Reynolds

May 13, 2019 at 10:20 am

CBD Switzerland. Whole Plant Extract From Swiss-Grown Industrial Hemp.

leave a comment »

Although something in my value system, no doubt instilled in my now very distant childhood, tells me that medicine is supposed to taste bad, there is no strict correlation between nasty taste and powerful effect.  Some cannabis extracts taste foul, others are bearable and there a few that capture the distinctive, earthy taste of the plant and are really very nice.

The first time I saw a bottle of CBD Switzerland oil, I was pretty sceptical.  It’s virtually crystal clear and I thought this is isolate in a carrier oil or it’s had all the goodness refined out of it – but the taste is just wonderful. The new trend for cooking with cannabis is a strange mix of hype, ignorance, fad-of-the-moment veganism and in a few cases its about getting high but there is a cannabis taste that is really desirable and works well in both sweet and savoury dishes.  CBD Switzerland has captured that taste in a bottle.

The lab tests and a week of regular use confirmed for me that this is very much the real thing.  There are other oils that I also rate very highly for taste but the combination of taste and clarity is stunning and I expect it is what more and more consumers will be looking for as the CBD market matures.  This is probably the most modern, consumer friendly oil on the market. No doubt, a little further down the line, the same expertise in extraction and refinement can be applied to a THC product and that will be a winner.

CBD Switzerland offers its oil in virtually any specification required, either zero THC or with the trace levels that are present in a full spectrum extract from plants with 0.2% THC.  Standard concentrations are 5%, 10%, 15%, 20% or 25% in either hempseed or MCT carrier oil.  Full spectrum soft gels are available containing 10mg CBD each.  Recently a THC-free distillate has been added with either 95% or 75% CBD content, a full spectrum, liposomal, water soluble mix and CBD vape liquid.  As a white label supplier, CBD Switzerland offers everything that a CBD business could need to formulate and produce its own products.

Download the CBD Switzerland brochure here.

Written by Peter Reynolds

April 25, 2019 at 3:42 pm

CannaPro Seizes the Initiative in the CBD and Novel Foods Debacle

with 2 comments

Cannabis Professionals (CannaPro), the trade association for the UK’s cannabis, CBD and hemp businesses, has instructed solicitors to take decisive action in the ongoing row between the Food Standards Agency (FSA) and the UK’s fastest-growing food supplement market for cannabidiol (CBD) products.

TLT Solicitors, acting on behalf of CannaPro, has sent a formal letter to the FSA warning it of the consequences of taking any enforcement action against CannaPro Certified Businesses.  An industry-wide claim for such compensation could amount to many hundreds of millions of pounds/euros.  A copy of the letter can be seen here. This offers some degree of protection to all businesses that are CannaPro Certified.

Acting in conjunction with its opposite numbers in several EU states, the FSA has sought to classify CBD products and all cannabis extracts as ‘novel’ by listing them in the EU Novel Food catalogue. This threatens to destroy a market that is now worth up to £100 million pa, employs hundreds of people and is meeting the healthcare and wellness needs of hundreds of thousands of UK citizens.

A ‘novel food’ is defined as a food or food ingredient that was not in widespread consumption in the EU area before 1997.  In reality, cannabis, in varieties known as hemp, has been consumed as food for at least 10,000 years and is listed in the Guinness Book of Records as the world’s oldest cultivated crop. The FSA’s action is irrational, defies history and reverses previous statements by the FSA that cannabis and hemp are not ‘novel’.

Peter Reynolds, president of CannaPro, said:

“The FSA has made a series of errors in the way it has handled this.  The whole process has been misguided and unlawful, not to say that the whole idea CBD products can be regarded as novel is nonsense. It has undertaken no proper consultation and although there have been vague discussions around the issue for a couple of years, the FSA has changed its position time and time again.  What’s really going on here is that big business and powerful vested interests have been caught on the hop while enterprising small businesses have established a market which is now worth an awful lot of money. Improper pressure has been brought on the regulator to find a way of clamping down.  It would suit these vested interests to see the market so strictly regulated that small businesses are unable to compete.  CannaPro is not going to stand by and let that happen.”

Written by Peter Reynolds

March 26, 2019 at 6:00 pm

CBD Isolates Are NOT Becoming A Controlled Substance

leave a comment »

Mike Harlington’s CTA has put out an announcement that CBD isolates are becoming a controlled substance.  There is no truth in this at all, it is nothing but speculation and opinion.

Even if the speculation is correct that isolates will remain classified as a novel food, the terminology is wrong. ‘Controlled’ has a specific meaning in UK law and is applied to drugs classified and scheduled under the Misuse of Drugs Act 1971.  There is no prospect whatsoever of this applying to CBD in any form.

It is correct that the FSA initially classified isolates as novel in January 2018 and no reasonable person can have any objection to this.  Clearly, there cannot be any evidence of them having been consumed in the EU area prior to 1997.  It’s a separate point that this is bureaucratic overkill.  There’s no evidence that isolates are unsafe so there’s no reason to require them to go through an authorisation process except simply to comply with the letter of the law. It is bureaucracy for bureaucracy’s sake and a complete waste of the FSA’s time and taxpayers’ money.

Another, more pertinent point is that despite isolates being classified as novel for well over a year, the FSA has done absolutely nothing about enforcement.  This whole rigmarole is pointless and doing little else other than keeping civil servants in work, making up rules which they then do nothing about.

What remains a far more worrying prospect, which has been entirely overlooked, is that in June 2018, the FSA also indicated that selective extracts would be regarded as novel. The argument for this is equally as strong and logical as it is for isolates and this poses a much more worrying prospect for the CBD industry.

Selective extracts are extracts in which the proportions of the component moleclues have been adjusted, most commonly by the elimination of THC.  Making such adjustments, dialling up or down particular components is an inherent facility of supercritical CO2 extraction. But just as there can be no evidence of isolates having been consumed in the EU area prior to 1997, neither can there be any for selective extracts.  Extracts consumed in the past will have been made by less sophisticated processes that do not permit such adjustments.

So the deep irony in this is that in order to avoid any infringement of drugs laws by removing the THC, such products will be in breach of food law.

Where the FSA is going with this no one knows. It has made major errors in its bungling and incompetent attempt to outlaw CBD products and its top priority now seems to be saving face.  Similarly, having bragged about his mythical ‘close working relationship’ with the FSA, Harlington is also desperately trying to save face and make it look as if he is ahead of the game.  It’s just more of his characteristic bluster and bullshit.  Don’t be taken in.

Any predictions I will make about the future will also be speculation but I am quite confident that this time next year whole plant, low-THC cannabis extracts will still be on sale. In fact I am sure that the market will have continued to expand rapidly.

Written by Peter Reynolds

March 13, 2019 at 10:35 pm